Table 1.
Serological biomarker levels of IgG4-RD patients in each subgroup after treatment.
| Variables | subgroup1 | subgroup2 | subgroup3 | P value (Univariate) |
|---|---|---|---|---|
| EOS% | 1.77 ± 2.08 | 1.87 ± 1.24 | 10.00 ± 11.39 | 0.001 |
| ESR (mm/h) | 9.52 ± 6.85 | 18.57 ± 19.07 | 30.33 ± 27.65 | 0.013 |
| IgG4 (mg/L) | 3172.07 ± 3171.98 | 2359.29 ± 1347.96 | 22575.00 ± 36497.76 | 0.008 |
| IgE (KU/L) | 87.12 ± 94.20 | 85.10 ± 174.10 | 788.73 ± 1003.21 | 0.002 |
P values in the univariate analysis were determined by one-way analysis of variance (ANOVA) or Kruskall-Wallis test. P-values < 0.05 were considered statistically significant. EOS%, percentage of eosinophil; ESR, erythrocyte sedimentation rate; IgG4, immunoglobulin G4.